Taking into account the official plans of the largest global car manufacturers, just the #Li_ion_batteries for them would require 250 tonnes of single wall #carbon_nanotubes (SWCNTs) in 2025.
The reproducible and durable #nanoscale device based on a unique material platform can achieve optimal digital in-memory #computing while being extremely energy efficient.
The #nanomaterials with enzyme-like characteristics developed by Chinese researchers can absorb and deactivate the #coronavirus (SARS-CoV-2) with 96.5 - 99.9 percent efficiency.
The rapid #COVID_19 test based on IgG-IgM combined #antibody and #gold_nanoparticles has great potential benefit for the fast screening of COVID-19 infections within 15 minutes.
Tailored surfaces formed of a mixture of #polyethylene and #graphite_nanoplatelets can kill 99.99 percent of #bacteria which try to attach to the surface.
SNALP is a #lipid_nanoparticle based #siRNA trigger formulation that comprises ionizable lipids, shielding lipids, cholesterol, and endogenous or exogenous targeting ligands such as ApoE lipoprotein.
Recent Alnylam advances in lung delivery technology suggest the possible utility of #RNAi therapeutic for the treatment of new #coronavirus disease (COVID-19).
#Ad5_nCoV is a genetically engineered #vaccine candidate with the replication-defective #adenovirus type 5 as a vector to express the spike protein of the novel #coronavirus (SARS-CoV-2).
A particular antibacterial substance composed of #titanium_dioxide and #silver nanoparticles makes the surfaces #self_sterilizing from six months to two years.
Using an insulation block #electrospinning process to manufacture orthogonal #nanofibers by controlling the alignment of nanofibers Korean researchers succeeded in developing a washable nanofiber-based face mask.
The colorimetric based #MIT technology can detect the #SARS_CoV_2 within 20 minutes using nanoparticle-bound #antibodies against a specific viral protein.
The first step in the clinical development of #Moderna's #mRNA vaccine against #SARS_CoV_2 (mRNA-1273) is being conducted by #NIH under its own Investigational New Drug application.
#mRNA technology has been widely used in many #nanotechnology_patents focusing on the #coronavirus (SARS / MERS) treatment approaches.
Around 5.2 percent (478 patents) of all #coronavirus related patents so far registered are in the field of #nanotechnology.
The future of #therapeutics is potent biological drugs, many of which have #delivery challenges with respect to how much drug needs to be delivered to exactly where in the body, while minimizing #side_effects.
A vast majority of #nanotechnology_patents on #coronaviruses have focused on the #diagnostic methods based on #CRISPR technology.
Loading #antiviral agents on #graphene_oxide (GO) enhances its biocompatibility while reducing the cytotoxicity of both GO and the antiviral agents.
New #COVID_19 vaccine candidate has been developed using proprietary #recombinant_protein nanoparticle technology platform to generate antigens derived from the #coronavirus spike (S) protein.
Due to their two-dimensional structure, sharp edges, and negatively charged surfaces, #graphene_oxide nanosheets are capable of interacting with microorganisms such as #bacteria and #viruses.